IBDEI0NI ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10584,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,10584,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,10584,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,10585,0)
 ;;=G31.89^^42^472^11
 ;;^UTILITY(U,$J,358.3,10585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10585,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System NEC
 ;;^UTILITY(U,$J,358.3,10585,1,4,0)
 ;;=4^G31.89
 ;;^UTILITY(U,$J,358.3,10585,2)
 ;;=^5003814
 ;;^UTILITY(U,$J,358.3,10586,0)
 ;;=G31.9^^42^472^12
 ;;^UTILITY(U,$J,358.3,10586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10586,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,10586,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,10586,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,10587,0)
 ;;=G23.8^^42^472^10
 ;;^UTILITY(U,$J,358.3,10587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10587,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,10587,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,10587,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,10588,0)
 ;;=G30.0^^42^472^2
 ;;^UTILITY(U,$J,358.3,10588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10588,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,10588,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,10588,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,10589,0)
 ;;=G30.1^^42^472^3
 ;;^UTILITY(U,$J,358.3,10589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10589,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,10589,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,10589,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,10590,0)
 ;;=B20.^^42^472^21
 ;;^UTILITY(U,$J,358.3,10590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10590,1,3,0)
 ;;=3^HIV Disease (AIDS Status)
 ;;^UTILITY(U,$J,358.3,10590,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,10590,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,10591,0)
 ;;=G10.^^42^472^23
 ;;^UTILITY(U,$J,358.3,10591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10591,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,10591,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,10591,2)
 ;;=^5003751
 ;;^UTILITY(U,$J,358.3,10592,0)
 ;;=G30.8^^42^472^1
 ;;^UTILITY(U,$J,358.3,10592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10592,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,10592,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,10592,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,10593,0)
 ;;=A81.89^^42^472^5
 ;;^UTILITY(U,$J,358.3,10593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10593,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,10593,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,10593,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,10594,0)
 ;;=G20.^^42^472^70
 ;;^UTILITY(U,$J,358.3,10594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10594,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,10594,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,10594,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,10595,0)
 ;;=G23.1^^42^472^74
 ;;^UTILITY(U,$J,358.3,10595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10595,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,10595,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,10595,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,10596,0)
 ;;=F03.91^^42^472^17
 ;;^UTILITY(U,$J,358.3,10596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10596,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
